Hsiang‐Chun Chen

The University of Texas MD Anderson Cancer Center

Papers

1

Total Citations

27

H-Index

1

About

Hsiang-Chun Chen is a leading researcher in urologic oncology, with a particular focus on patient-centered outcomes following prostate cancer treatment. Her work critically examines the comparative effectiveness and quality-of-life (QoL) implications of different therapeutic modalities. In her landmark 2017 prospective cohort study, Chen provided essential comparative data on QoL after brachytherapy versus bilateral nerve-sparing robot-assisted radical prostatectomy for non-metastatic prostate cancer. This highly cited work (27 citations) directly addresses a crucial gap in clinical decision-making, empowering patients to make more informed treatment choices based on real-world functional outcomes rather than solely on oncological efficacy. By rigorously assessing patient-reported QoL, Chen’s research has helped shift the conversation in urologic oncology toward a more holistic view of treatment success, one that values the patient’s lived experience as much as cancer control. Her contributions are vital for clinicians and researchers striving to balance cancer cure with the preservation of long-term quality of life.

Research Focus

Key Achievements

1
H-Index
1
Papers
27
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Quality of life after brachytherapy or bilateral nerve‐sparing robot‐assisted radical prostatectomy for prostate cancer: a prospective cohort
27 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago